Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapy.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

5 citing papers in PubMed.

1. Advances in the understanding of Mycobacterium tuberculosis transmission in HIV-endemic settings.The Lancet. Infectious diseases · 2019
   Review
2. Performance of symptom-based tuberculosis screening among people living with HIV: not as great as hoped.AIDS (London, England) · 2014
   Article
3. Interferon release does not add discriminatory value to smear-negative HIV-tuberculosis algorithms.The European respiratory journal · 2012
   Article
4. HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis.European journal of immunology · 2012
   Article
5. Altered ratio of IFN-γ/IL-10 in patients with drug resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome.PloS one · 2012
   Article

Corrections and comments

• Comment on
  Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.2010

Authors and funding

2 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as